|
Home : Unsafe Drugs : Avandia : Newsfeeds : GlaxoSmithKline to take $3.4 bln charge on Avandia GlaxoSmithKline to take $3.4 bln charge on Avandia
LONDON (AP) -- Pharmaceutical company GlaxoSmithKline PLC said Monday it will take a 2.2 billion pounds ($3.4 billion) charge against earnings in the fourth quarter to provide for litigation over its diabetes drug, Avandia. The company said the charge is ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




